Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...
We recently published 10 Stocks on Jim Cramer’s Radar. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Eli Lilly and Company (NYSE:LLY) continues to be one of ...
Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market expectations, driven by unprecedented demand for its ...
The AI chip darling already has the most cutting-edge products and the best customers. The next thing to do is to find more of them.
Investor's Business Daily on MSN
S&P 500 Giants JPMorgan, Eli Lilly Lead Five Stocks Near Buy Points
S &P 500 giants Eli Lilly LLY and JPMorgan Chase JPM are stocks to watch this coming week. So is Interactive Brokers IBKR, ...
Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
Gary Walter Davaney, a man whose kindness, humor, energy, and unforgettable spirit touched countless lives, passed away after a courageous 21-year battle with cancer.
The Score is a weekly review of the biggest stock moves and the news that drove them. Here are six stocks that drew the spotlight this week.
AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.
Eli Lilly, Zyrtec and Astellas Pharma recently invested in celeb partnerships to raise awareness about conditions.
The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results